English | 繁體

Search in the results

UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Anti-migratory Properties of Cryoprotective Isoliquiritigenin-zein Phosphatidylcholine Nanoparticles Prevent Triple-negative Breast Cancer through PI3K-mTOR and MMP2/9 Pathways Journal article
Xu, Cong, Zhang, Chen, Ganesan, Kumar, Chen, Qiu, Tang, Hailin, Gao, Fei, Liu, Qingqing, Wu, Jianming, Sui, Yue, Li, Peng, Zhang, Jinming, Chen, Jianping. Anti-migratory Properties of Cryoprotective Isoliquiritigenin-zein Phosphatidylcholine Nanoparticles Prevent Triple-negative Breast Cancer through PI3K-mTOR and MMP2/9 Pathways[J]. Current Medicinal Chemistry, 2023.
Authors:  Xu, Cong;  Zhang, Chen;  Ganesan, Kumar;  Chen, Qiu;  Tang, Hailin; et al.
Favorite |   IF:3.5/4.0 | Submit date：2024/07/03
A tumor-targeted delivery of oral isoliquiritigenin through encapsulated zein phosphatidylcholine hybrid nanoparticles prevents triple-negative breast cancer Journal article
Wang, Yan, Zhang, Chen, Xiao, Meng, Ganesan, Kumar, Gao, Fei, Liu, Qingqing, Ye, Zhen, Sui, Yue, Zhang, Feng, Wei, Kunhua, Wu, Yaobin, Wu, Jianmin, Du, Bing, Xu, Cong, Li, Yan, Li, Peng, Zhang, Jinming, Chen, Jianping. A tumor-targeted delivery of oral isoliquiritigenin through encapsulated zein phosphatidylcholine hybrid nanoparticles prevents triple-negative breast cancer[J]. Journal of Drug Delivery Science and Technology, 2023, 79.
Authors:  Wang, Yan;  Zhang, Chen;  Xiao, Meng;  Ganesan, Kumar;  Gao, Fei; et al.
Favorite | TC[WOS]:12 TC[Scopus]:12  IF:4.5/4.7 | Submit date：2023/02/01
Isoliquiritigenin  Zein-phosphatidylcholine Hybrid Nanoparticles  Bioavailability  Triple-negative Breast Cancer  Safe Therapeutic Strategy  
Targeting engineered nanoparticles for breast cancer therapy Journal article
Ganesan, Kumar, Wang, Yan, Gao, Fei, Liu, Qingqing, Zhang, Chen, Li, Peng, Zhang, Jinming, Chen, Jianping. Targeting engineered nanoparticles for breast cancer therapy[J]. Pharmaceutics, 2021, 13(11).
Authors:  Ganesan, Kumar;  Wang, Yan;  Gao, Fei;  Liu, Qingqing;  Zhang, Chen; et al.
Favorite | TC[WOS]:44 TC[Scopus]:47  IF:4.9/5.5 | Submit date：2021/12/08
Breast Cancer  Engineering  Ligands  Nanoparticles  Therapeutic Effects  
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 Other
2016-01-01
Authors:  Klionsky, Daniel J.;  Abdelmohsen, Kotb;  Abe, Akihisa;  Abedin, Md Joynal;  Abeliovich, Hagai; et al.
Favorite | TC[WOS]:408 TC[Scopus]:24 | Submit date：2022/07/20